Latest

• Combination of gastroprotectors and probiotics in the eradication of H. pylori infection: results of a randomized comparative clinical trial

  Clinical Microbiology and Antimicrobial Chemotherapy. 2023; 25(2):142-149

• COVID-19 risk factors for mortality in hospitalized patients: results of a retrospective study

  Clinical Microbiology and Antimicrobial Chemotherapy. 2023; 25(1):93-99

• Results of an open-label, randomized, comparative clinical trial of nifuratel in the eradication of Helicobacter pylori infection in adult patients

  Clinical Microbiology and Antimicrobial Chemotherapy. 2020; 22(2):119-127

• Pharmacoepidemiology of peptic ulcer in Smolensk: 15 years later

  Clinical Microbiology and Antimicrobial Chemotherapy. 2019; 21(2):84-90

• Comparison of in vitro activity of various macrolides against Helicobacter pylori

  Clinical Microbiology and Antimicrobial Chemotherapy. 2018; 20(3):192-197

• Antimicrobial resistance of Helicobacter pylori in Smolensk

  Clinical Microbiology and Antimicrobial Chemotherapy. 2018; 20(1):42-48

• The Summary of Expert Meeting «Managing Patients with Helicobacter pylori Infection: From Simple to Complex»

  Clinical Microbiology and Antimicrobial Chemotherapy. 2014; 16(3):176-184